PubRank

J R Masters

Author PubWeight™ 61.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect 2001 2.03
2 Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 1986 1.94
3 Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 1996 1.79
4 Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 2000 1.66
5 Cyclic Variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 1977 1.56
6 Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 1999 1.52
7 Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 2001 1.50
8 Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene 2007 1.46
9 Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. Eur J Cancer 1978 1.43
10 Immortalisation of human urothelial cells. Urol Res 1995 1.38
11 Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 1991 1.36
12 Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines. Cancer Res 1988 1.32
13 21st century molecular biology in urology. BJU Int 2001 1.14
14 DNA repair capacity and cisplatin sensitivity of human testis tumour cells. Int J Cancer 1997 1.10
15 Epithelial-mesenchymal interaction during lung development: the effect of mesenchymal mass. Dev Biol 1976 1.01
16 Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization. J Urol 1985 1.00
17 Culture and characterisation of human urothelium in vivo and in vitro. Urol Res 1994 0.99
18 Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs. J Natl Cancer Inst 1987 0.96
19 Elastosis and oestrogen receptors in human breast cancer. Br J Cancer 1976 0.96
20 Histological grade and response to endocrine therapy in breast cancer. Lancet 1981 0.94
21 Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide. Br J Cancer 1995 0.94
22 Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro. Eur J Cancer 1992 0.92
23 Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer. Br J Cancer 1987 0.90
24 Elastosis and response to endocrine therapy in human breast cancer. Br J Cancer 1979 0.90
25 O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines. Br J Cancer 1992 0.87
26 Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH. Prostate Cancer Prostatic Dis 2005 0.87
27 Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity. Urol Res 1986 0.86
28 Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy. Cancer Res 1989 0.84
29 Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines. Eur J Cancer 1990 0.84
30 DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction. Biochem Pharmacol 1996 0.84
31 Response to endocrine therapy and breast cancer differentiation. Breast Cancer Res Treat 1986 0.84
32 Human bladder cancer in vitro drug sensitivities: range and stability in long-term culture. Br J Cancer 1986 0.83
33 The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene. Int J Cancer 1992 0.83
34 Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells. Anticancer Res 2001 0.82
35 Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity. Cancer 1986 0.82
36 Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. Urol Res 1985 0.82
37 Response to epirubicin in patients with superficial bladder cancer and expression of the topoisomerase II alpha and beta genes. Int J Cancer 1996 0.81
38 Hormonal sensitivity of human breast tumors in vitro: pentose-shunt activity. Cancer 1977 0.81
39 Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin. Br J Urol 1994 0.81
40 The biological and clinical significance of HCG-containing cells in seminoma. Br J Cancer 1985 0.80
41 Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies. Cancer Res 1990 0.79
42 Genetic basis of drug sensitivity in human testis tumour cells. Int J Cancer 1996 0.79
43 In vitro assessment of a collagen sponge for engineering urothelial grafts. Br J Urol 1998 0.79
44 Prognostic markers in clinically localised prostate cancer. Int J Oncol 1999 0.79
45 Quantitative organ culture: an approach to prediction of tumour response. Br J Cancer Suppl 1980 0.79
46 How diagnosis with microarrays can help cancer patients. Nature 2000 0.78
47 The incidence and influence upon fertility of antisperm antibodies in seminal fluid following vasectomy reversal. Int J Androl 1989 0.78
48 Differential sensitivities to gamma radiation of human bladder and testicular tumour cell lines. Int J Radiat Biol Relat Stud Phys Chem Med 1988 0.78
49 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro. J Clin Endocrinol Metab 1996 0.78
50 Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. Br J Cancer 1999 0.78
51 Association between infertility following reversal of vasectomy and the presence of sperm agglutinating activity in semen. Int J Androl 1984 0.78
52 The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum. Int J Radiat Oncol Biol Phys 1993 0.78
53 Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin. Int J Cancer 1987 0.78
54 Serum and tissue tumour markers in seminomas. Br J Urol 1985 0.77
55 Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro. J Steroid Biochem Mol Biol 1994 0.77
56 Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro. Urol Res 1988 0.77
57 Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II). Chem Biol Interact 1987 0.77
58 [Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells]. Verh Dtsch Ges Pathol 1993 0.77
59 Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro. BJU Int 2000 0.76
60 Complementation analysis of testis tumor cells. Cancer Genet Cytogenet 1997 0.76
61 Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice. Br J Urol 1985 0.76
62 Human breast carcinomata in organ culture: the effect of hormones. Br J Cancer 1976 0.75
63 Re: methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 2001 0.75
64 Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat. Br J Cancer 1995 0.75
65 Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro. Cancer Chemother Pharmacol 1986 0.75
66 Glyoxalase activity in human tumour cell lines in vitro. Biochem Soc Trans 1993 0.75
67 Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro. Urol Res 1987 0.75
68 pSV3neo transfection and radiosensitivity of human cancer cell lines. Cancer Lett 1990 0.75
69 Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity. J Urol 1986 0.75
70 Mouse-human somatic cell hybrids: loss of mouse and human chromosomes. Somat Cell Mol Genet 1998 0.75
71 Experimental trypsin-induced urothelial cell separation in vivo. Br J Urol 1980 0.75
72 Altered androgen metabolism in carcinoma of the prostate. Eur Urol 1981 0.75
73 HCG localisation of no prognostic value in testicular teratoma. Lancet 1981 0.75
74 Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines. Urol Res 1995 0.75
75 Proceedings: Effect of hormones on the maintenance of human breast carcinomas in organ culture. Br J Surg 1976 0.75
76 Androgen metabolism by human prostatic tumours in organ culture. Eur J Cancer Clin Oncol 1983 0.75
77 Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro. Invest New Drugs 1984 0.75
78 [Distribution pattern of urothelial associated glycoproteins in human bladder cancer cell lines in in vitro culture]. Verh Dtsch Ges Pathol 1993 0.75
79 Human benign prostatic hyperplasia in organ culture: studies on iododeoxyuridine uptake. Prostate 1983 0.75
80 In vitro responses of human prostate tumour cell lines to a range of antitumour agents. Int J Cancer 1983 0.75
81 Factors influencing the outcome of vasectomy reversal. Br J Urol 1980 0.75
82 The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro. Urol Res 1990 0.75
83 The prevalence and prognostic significance of trophoblastic proteins in testicular teratoma. Diagn Histopathol 1984 0.75
84 The effect of carcinogens on mitotic frequency in mouse lung primordia in vitro. Eur J Cancer 1976 0.75
85 The Makari skin test and immunocompetence in bladder cancer. Urol Res 1980 0.75
86 Intravesical chemotherapy. Lancet 1986 0.75
87 [Three dimensional cell culture in vitro for the analysis of proliferation and differentiation of urinary bladder carcinoma]. Verh Dtsch Ges Pathol 1988 0.75
88 KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation. Biochem Pharmacol 1998 0.75